Source:http://linkedlifedata.com/resource/pubmed/id/11786520
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2002-1-11
|
pubmed:abstractText |
Mitral regurgitation (MR) causes ventricular dilation, a blunted myocardial force-frequency relation, and increased crossbridge force-time integral (FTI). The mechanism of FTI increase was investigated using sinusoidal length perturbation analysis to compare crossbridge function in skinned left ventricular (LV) epicardial muscle strips from 5 MR and 5 nonfailing (NF) control hearts. Myocardial dynamic stiffness was modeled as 3 parallel viscoelastic processes. Two processes characterize intermediate crossbridge cycle transitions, B (work producing) and C (work absorbing) with Q(10)s of 4 to 5. No significant differences in moduli or kinetic constants of these processes were observed between MR and NF. The third process, A, characterizes a nonenzymatic (Q(10)=0.9) work-absorbing viscoelasticity, whose modulus increases sigmoidally with [Ca(2+)]. Effects of temperature, crossbridge inhibition, or variation in [MgATP] support associating the calcium-dependent portion of A with the structural "backbone" of the myosin crossbridge. Extension of the conventional sinusoidal length perturbation analysis allowed using the A modulus to index the lifetime of the prerigor, AMADP crossbridge. This index was 75% greater in MR than in NF (P=0.02), suggesting a mechanism for the previously observed increase in crossbridge FTI. Notably, the A-process modulus was inversely correlated (r(2)=0.84, P=0.03) with in vivo LV ejection fraction in MR patients. The longer prerigor dwell time in MR may be clinically relevant not only for its potential role as a compensatory mechanism (increased economy of tension maintenance and increased resistance to ventricular dilation) but also for a potentially deleterious effect (reduced elastance and ejection fraction).
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1524-4571
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
11
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
66-72
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11786520-Adenosine Triphosphate,
pubmed-meshheading:11786520-Aged,
pubmed-meshheading:11786520-Calcium,
pubmed-meshheading:11786520-Dose-Response Relationship, Drug,
pubmed-meshheading:11786520-Female,
pubmed-meshheading:11786520-Heart,
pubmed-meshheading:11786520-Heart Failure,
pubmed-meshheading:11786520-Humans,
pubmed-meshheading:11786520-Male,
pubmed-meshheading:11786520-Middle Aged,
pubmed-meshheading:11786520-Mitral Valve Insufficiency,
pubmed-meshheading:11786520-Myocardial Contraction
|
pubmed:year |
2002
|
pubmed:articleTitle |
Alterations of myocardial dynamic stiffness implicating abnormal crossbridge function in human mitral regurgitation heart failure.
|
pubmed:affiliation |
Department of Molecular Physiology & Biophysics, University of Vermont, Burlington 05405-0068, USA. mulieri@physiology.med.uvm.edu
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.
|